Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$461.12 USD

461.12
2,573,707

+6.11 (1.34%)

Updated Jul 22, 2024 04:00 PM ET

After-Market: $459.58 -1.54 (-0.33%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (143 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Baxter (BAX) Launches Arisure Closed System Transfer Device

Baxter's (BAX) Arisure Closed System reduces exposure risk of healthcare professionals to needles. Also, the latest development promotes safe handling of hazardous drugs.

    Abbott's (ABT) Diabetes Care Unit Strong on FreeStyle Libre

    Abbott (ABT) forges ahead with initiatives to boost diabetes care. The latest CMS recognition will widen customer base for FreeStyle Libre glucose monitoring system.

      Integra LifeSciences Estimates Strong Revenue Figures for Q4

      Integra LifeSciences (IART) sees strong organic growth in the company's Specialty Surgical Solutions as well as Orthopedics and Tissue Technologies businesses.

        Intuitive Surgical (ISRG) Upbeat on Q4 & 2017 Sales Results

        Intuitive Surgical (ISRG) optimistic about fourth-quarter and 2017 net sales outcome on revenue growth across all business segments.

          The Zacks Analyst Blog Highlights: Macy???s, Target, SS&C Technologies, Intuitive Surgical and Brighthouse Financial

          The Zacks Analyst Blog Highlights: Macy???s, Target, SS&C Technologies, Intuitive Surgical and Brighthouse Financial

            Abaxis' (ABAX) Preliminary Results for Q3 Cheer Investors

            Abaxis (ABAX) expects substantial tax savings from the recent U.S. tax reform.

              Hill-Rom (HRC) Estimates Strong Revenue Figures for Q1

              Hill-Rom (HRC) expects substantial tax savings from the recent U.S. tax reform.

                Benjamin Rains headshot

                Buy These 3 Stocks on Today's Strong Gains

                The New Year has been dominated by cryptocurrencies and blockchain technology, with unlikely companies such as Kodak (KODK) jumping on the bandwagon after announcing its new KODAKCoin and KODAKOne platform.

                  NuVasive Q4 Preliminary Results Fail to Cheer Investors

                  NuVasive (NUVA) continues to witness sequential growth in international revenues and expects substantial tax savings from the recent U.S. tax reform.

                    DexCom Estimates Strong Revenue Figures for Q4 and 2017

                    Dexcom (DXCM) to gain from strong sensor volumes, international revenues and expanding worldwide patient base in 2018.

                      RTI Surgical (RTIX) to Acquire Zyga, Improve Spine Surgeries

                      RTI Surgical (RTIX) to integrate Zyga's SImmetry Sacroiliac Joint Fusion System to diversify Spine franchise.

                        FDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty Arm

                        Zimmer Biomet's (ZBH) Sidus Stem-Free Shoulder system offers a minimal bone resection in total shoulder arthroplasty, which the company claims to help reduce pain and restore a range of motions.

                          McKesson Buys RxCrossroads from CVS Health for $735 Million

                          McKesson (MCK) has been actively pursuing deals, divestitures and acquisitions to drive growth. The latest buyout will boost Specialty Health business.

                            Walgreens Boots (WBA) Tops Q1 Earnings, Margins Decline

                            Walgreens Boots (WBA) surpasses the Zacks Consensus Estimate for both the counts in Q1 on continued prescription growth and strength in the Retail Pharmacy USA division.

                              Neogen (NEOG) Q2 Earnings Beat Estimates, Revenues Miss

                              Neogen (NEOG) rides high on balanced growth across all business segments in Q2.

                                Stryker's Global Foothold Strong Amid Product Recall Issue

                                Stryker (SYK) enjoys strong foothold in the European and Australian markets. On the flip side, the company witnesses lower demand for health care products.

                                  5 Reasons Why You Should Buy Abiomed (ABMD) Stock Right Now

                                  Abiomed (ABMD) gains from solid product portfolio. Also, impressive performance on the bourses instills investor's optimism on the stock.

                                    Intuitive Surgical Banks on da Vinci X, Forex Woes Remain

                                    Intuitive Surgical's (ISRG) consistent efforts to boost da Vinci X platform is a positive. However, foreign exchange movements are impacting the company's results

                                      Mark Vickery headshot

                                      Top Stock Reports for Nike, PayPal & BNY Mellon

                                      Today's Research Daily features new research reports on 16 major stocks, including Nike (NKE), PayPal (PYPL) and BNY Mellon (BK).

                                        Intuitive Surgical Hits a 52-Week High on Solid Prospects

                                        The market is upbeat about Intuitive Surgical's (ISRG) solid procedure performance in Asia, with growth in China, Japan and Korea.

                                          Why Is Intuitive Surgical (ISRG) Up 9.8% Since the Last Earnings Report?

                                          Intuitive Surgical (ISRG) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                            The Zacks Analyst Blog Highlights: Baxter International, BostonScientific, Intuitive Surgical and Becton and Dickinson

                                            The Zacks Analyst Blog Highlights: Baxter International, BostonScientific, Intuitive Surgical and Becton and Dickinson

                                              Trump Focuses on APAC: 4 MedTech Stocks to Watch

                                              Considering Trump's growing focus on APAC, the region seems to be poised to yield accretive returns over the long term. Favorable MedTech trends in APAC hold promise.

                                                Intuitive Surgical (ISRG) to Gain From Procedural Business

                                                Intuitive Surgical's (ISRG) sales to gain from on da Vinci system and procedural growth in general surgery, oncology, urology and gynecology.

                                                  Are Options Traders Betting on a Big Move in Intuitive Surgical (ISRG) Stock?

                                                  Investors in Intuitive Surgical (ISRG) need to pay close attention to the stock based on moves in the options market lately.